BMS-986278, BMS-986278 Placebo — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10-06 in 4mo
ESTIMATED |
READOUT
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Part
Phase 3 · Idiopathic Pulmonary Fibrosis |
BMY BRISTOL MYERS SQUIBB CO | BMS-986278, BMS-986278 Placebo |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|